The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice

Uncontrolled chronic inflammation and necrosis is characteristic of inflammatory bowel disease (IBD). This study aimed to investigate the effect of necrosis inhibitor (NI, NecroX-7) on a dextran sulfate sodium (DSS) induced chronic colitis model of mice. DSS was administered on days 1–5, and the NI...

Full description

Bibliographic Details
Main Authors: Dongwoo Kim, Ja Seol Koo, Soon Ha Kim, Yeong Seo Park, Jung Wan Choe, Seung Young Kim, Jong Jin Hyun, Sung Woo Jung, Young Kul Jung, Hyung Joon Yim
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/1/222
_version_ 1797437780645642240
author Dongwoo Kim
Ja Seol Koo
Soon Ha Kim
Yeong Seo Park
Jung Wan Choe
Seung Young Kim
Jong Jin Hyun
Sung Woo Jung
Young Kul Jung
Hyung Joon Yim
author_facet Dongwoo Kim
Ja Seol Koo
Soon Ha Kim
Yeong Seo Park
Jung Wan Choe
Seung Young Kim
Jong Jin Hyun
Sung Woo Jung
Young Kul Jung
Hyung Joon Yim
author_sort Dongwoo Kim
collection DOAJ
description Uncontrolled chronic inflammation and necrosis is characteristic of inflammatory bowel disease (IBD). This study aimed to investigate the effect of necrosis inhibitor (NI, NecroX-7) on a dextran sulfate sodium (DSS) induced chronic colitis model of mice. DSS was administered on days 1–5, and the NI was administered intraperitoneally (3 mg/kg, 30 mg/kg) on days 1, 3, and 5 as well as every other day during the first five days of a three-week cycle. Three cycles of administration were performed. Colitis was evaluated based on the disease activity index (DAI) score, colon length, and histological score. Reverse transcription polymerase chain reaction testing, the Western blot assay, and immunohistochemical staining were performed to determine inflammatory cytokine levels. The NI reduced body weight change and the DAI score. Colon length and the histological score were longer and lower in the NI-treated groups, respectively. The NI decreased the expression of pro-inflammatory cytokines, particularly in tumor necrosis factor alpha (TNF-α) and phosphorylated nuclear factor kappa B (p-NF-κB). Immunohistochemical staining revealed decreased inducible nitric oxide synthase (iNOS) and high mobility group box 1 (HMGB1) levels. Overall, the NI improved DSS induced chronic colitis by attenuating the mRNA expression of pro-inflammatory cytokines such as TNF-α. Therefore, NI use is a potential, novel treatment approach for IBD.
first_indexed 2024-03-09T11:27:33Z
format Article
id doaj.art-6e0088289ce140f689b0ee9868c3aa28
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T11:27:33Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-6e0088289ce140f689b0ee9868c3aa282023-11-30T23:59:23ZengMDPI AGPharmaceutics1999-49232023-01-0115122210.3390/pharmaceutics15010222The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in MiceDongwoo Kim0Ja Seol Koo1Soon Ha Kim2Yeong Seo Park3Jung Wan Choe4Seung Young Kim5Jong Jin Hyun6Sung Woo Jung7Young Kul Jung8Hyung Joon Yim9Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaMitoImmune Therapeutics Inc., Seoul 06123, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Seoul 02841, Republic of KoreaUncontrolled chronic inflammation and necrosis is characteristic of inflammatory bowel disease (IBD). This study aimed to investigate the effect of necrosis inhibitor (NI, NecroX-7) on a dextran sulfate sodium (DSS) induced chronic colitis model of mice. DSS was administered on days 1–5, and the NI was administered intraperitoneally (3 mg/kg, 30 mg/kg) on days 1, 3, and 5 as well as every other day during the first five days of a three-week cycle. Three cycles of administration were performed. Colitis was evaluated based on the disease activity index (DAI) score, colon length, and histological score. Reverse transcription polymerase chain reaction testing, the Western blot assay, and immunohistochemical staining were performed to determine inflammatory cytokine levels. The NI reduced body weight change and the DAI score. Colon length and the histological score were longer and lower in the NI-treated groups, respectively. The NI decreased the expression of pro-inflammatory cytokines, particularly in tumor necrosis factor alpha (TNF-α) and phosphorylated nuclear factor kappa B (p-NF-κB). Immunohistochemical staining revealed decreased inducible nitric oxide synthase (iNOS) and high mobility group box 1 (HMGB1) levels. Overall, the NI improved DSS induced chronic colitis by attenuating the mRNA expression of pro-inflammatory cytokines such as TNF-α. Therefore, NI use is a potential, novel treatment approach for IBD.https://www.mdpi.com/1999-4923/15/1/222necrosis inhibitorchronic colitisinflammatory bowel disease
spellingShingle Dongwoo Kim
Ja Seol Koo
Soon Ha Kim
Yeong Seo Park
Jung Wan Choe
Seung Young Kim
Jong Jin Hyun
Sung Woo Jung
Young Kul Jung
Hyung Joon Yim
The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
Pharmaceutics
necrosis inhibitor
chronic colitis
inflammatory bowel disease
title The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
title_full The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
title_fullStr The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
title_full_unstemmed The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
title_short The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice
title_sort effect of necrosis inhibitor on dextran sulfate sodium induced chronic colitis model in mice
topic necrosis inhibitor
chronic colitis
inflammatory bowel disease
url https://www.mdpi.com/1999-4923/15/1/222
work_keys_str_mv AT dongwookim theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jaseolkoo theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT soonhakim theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT yeongseopark theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jungwanchoe theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT seungyoungkim theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jongjinhyun theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT sungwoojung theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT youngkuljung theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT hyungjoonyim theeffectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT dongwookim effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jaseolkoo effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT soonhakim effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT yeongseopark effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jungwanchoe effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT seungyoungkim effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT jongjinhyun effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT sungwoojung effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT youngkuljung effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice
AT hyungjoonyim effectofnecrosisinhibitorondextransulfatesodiuminducedchroniccolitismodelinmice